348 related articles for article (PubMed ID: 23288945)
21. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers.
Gerend MA; Shepherd MA; Lustria ML
Sex Transm Dis; 2013 May; 40(5):401-5. PubMed ID: 23588130
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake.
Donadiki EM; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; López de Andrés A; Velonakis EG
Vaccine; 2012 Nov; 30(49):6967-70. PubMed ID: 23022147
[TBL] [Abstract][Full Text] [Related]
23. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic HPV vaccination for the prevention of cervical cancer.
Hernandez BY
Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
[No Abstract] [Full Text] [Related]
25. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
26. [Vaccination against HPV in adults].
Gil Á
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
[No Abstract] [Full Text] [Related]
27. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010.
Bednarczyk RA; Birkhead GS; Morse DL; Doleyres H; McNutt LA
Vaccine; 2011 Apr; 29(17):3138-43. PubMed ID: 21376797
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus vaccine in adolescent women: a 2012 update.
Etter DJ; Zimet GD; Rickert VI
Curr Opin Obstet Gynecol; 2012 Oct; 24(5):305-10. PubMed ID: 22781077
[TBL] [Abstract][Full Text] [Related]
29. HPV prevention and the promise of the new vaccines.
Allred S; Cox JT; Mahoney M
J Am Acad Nurse Pract; 2006; 18 Suppl 2():1-11. PubMed ID: 17474243
[No Abstract] [Full Text] [Related]
30. Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer.
Wu TC
Eur J Immunol; 2007 Feb; 37(2):310-4. PubMed ID: 17273998
[TBL] [Abstract][Full Text] [Related]
31. Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine.
Lee FH; Paz-Soldan VA; Carcamo C; Garcia PJ
J Low Genit Tract Dis; 2010 Apr; 14(2):113-7. PubMed ID: 20354419
[TBL] [Abstract][Full Text] [Related]
32. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
[TBL] [Abstract][Full Text] [Related]
33. The acceptability of human papillomavirus (HPV) vaccination among women with physical disabilities.
Yen CF; Chen SF; Lin LP; Hsu SW; Chang MJ; Wu CL; Lin JD
Res Dev Disabil; 2011; 32(5):2020-6. PubMed ID: 21571498
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus vaccine: widening the scope for cancer prevention.
No JH; Kim MK; Jeon YT; Kim YB; Song YS
Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
[TBL] [Abstract][Full Text] [Related]
35. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
Stanley M
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
[TBL] [Abstract][Full Text] [Related]
36. Young adults and acceptance of the human papillomavirus vaccine.
Lenselink CH; Schmeink CE; Melchers WJ; Massuger LF; Hendriks JC; van Hamont D; Bekkers RL
Public Health; 2008 Dec; 122(12):1295-301. PubMed ID: 18619631
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students.
Chelimo C; Wouldes TA; Cameron LD
Sex Health; 2010 Sep; 7(3):394-6. PubMed ID: 20719233
[TBL] [Abstract][Full Text] [Related]
38. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus vaccine acceptability among young adult men.
Gerend MA; Barley J
Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
[TBL] [Abstract][Full Text] [Related]
40. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.
Schwarz TF
Expert Rev Vaccines; 2008 Dec; 7(10):1465-73. PubMed ID: 19053203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
